Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
ULTRATAG RBC CURIUM CANADA INC Resolved 20MCI Updated Report 2024-06-12 228585
OMNIPAQUE 240 GE HEALTHCARE CANADA INC Resolved 518MG Updated Report 2024-06-12 229037
TRAVATAN Z NOVARTIS PHARMACEUTICALS CANADA INC Actual shortage 0.004% Updated Report 2024-06-12 230095
CAMPRAL MYLAN PHARMACEUTICALS ULC Actual shortage 333MG Updated Report 2024-06-12 228363
!!T3 JAMP-CHOLESTYRAMINE JAMP PHARMA CORPORATION Actual shortage 4G Updated Report 2024-06-11 211780
ACH-LETROZOLE ACCORD HEALTHCARE INC Actual shortage 2.5MG Updated Report 2024-06-11 217355
MYLAN-VALACYCLOVIR MYLAN PHARMACEUTICALS ULC Anticipated shortage 500MG Updated Report 2024-06-11 230137
MYLAN-VALACYCLOVIR MYLAN PHARMACEUTICALS ULC Resolved 500MG Updated Report 2024-06-11 228375
MYLAN-AMLODIPINE/ATORVASTATIN MYLAN PHARMACEUTICALS ULC Actual shortage 80MG 10MG Updated Report 2024-06-11 217876
DILANTIN-125 SUSPENSION BGP PHARMA ULC Actual shortage 125MG New Report 2024-06-11 230126

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
FOSRENOL TAKEDA CANADA INC Discontinued 500MG Updated Report 2024-06-10 228178
GLUCONORM 2.0MG NOVO NORDISK CANADA INC To be discontinued 2.0MG Updated Report 2024-06-05 201489
ISENTRESS MERCK CANADA INC To be discontinued 100MG Updated Report 2024-06-04 204160
PRO-DESVENLAFAXINE PRO DOC LIMITEE Discontinued 100MG New Report 2024-06-04 229623
PRO-DESVENLAFAXINE PRO DOC LIMITEE Discontinued 50MG New Report 2024-06-04 229620